Northrop Grumman is rated a buy with a $754.75 price target, driven by a recent 25% increase in B-21 Raider production that is not yet reflected in company guidance. This suggests potential upward revisions as the program moves beyond its low-rate initial production phase and margins improve. While Sentinel ICBM cost overruns pose a margin risk, ongoing congressional funding and strategic necessity make cancellation unlikely. Additionally, Northrop Grumman's early leadership in autonomous aircraft and drone technology positions it for significant long-term revenue growth.
Northrop Grumman has started construction on a new building at its Roy Innovation Center in Utah to support the U.S. Air Force Sentinel Intercontinental Ballistic Missile program and other aerospace missions. This expansion will add to the existing c...
Small-cap stocks in the U.S. market continue to be the most undervalued segment, even after their best first-half performance in over 30 years, according to Morningstar's Q3 2026 outlook. The overall market shows a modest 8% discount to fair value, b...
